Harprit Singh: Future – Ready Hospitals Will Have Apheresis Hubs, Not Just Dialysis Units
Harprit Singh, Associate Director at Transfusion Technologies, Therapies, Solutions and Consultant in Transfusion Medicine at Alchemist Hospital, shared a post on LinkedIn:
“Future – Ready Hospitals Will Have Apheresis Hubs – Not Just Dialysis Units
Most hospitals don’t have an apheresis problem.
They have a utilization problem.
In multiple institutions I’ve worked with, the pattern is consistent:
- Apheresis machines exist.
- Clinical expertise exists.
- But activation pathways don’t.
The result?
- Delayed therapeutic plasma exchange (TPE)
- Underutilized apheresis services
- Missed integration with solid organ and bone marrow transplant (BMT) and oncology
- Higher ICU burden and avoidable costs
This is where strategy changes everything.
Hospitals that build Clinical Apheresis Hubs – not fragmented services – unlock the following:
- Faster intervention in critical care
- Seamless transplant and cellular therapy workflows
- Reduced ICU dependency
High-value, predictable clinical revenue
Because an Apheresis Hub is not equipment.
It is a clinical plus operational plus financial system.
Protocols define speed
Ownership defines utilisation.
The question is no longer:
‘Do we have apheresis?’
It is:
‘Is it integrated into how we deliver care?’
For COs and administrators, this is where transfusion medicine becomes strategy – not support.
A practical starting point:
Map 3 things
Who triggers apheresis?
How fast can it be activated?
How often is iused?
An open question:
What is the single biggest barrier to apheresis utilisation in your institution today?”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 14:02Hasan Burak İşleyen։ Thrombocytopenia and Mortality in Critically Ill Cancer Patients
-
Nov 20, 2026, 13:50Louise Maes: CONVINCE Trial Imaging Studies Reveal New Insights Into Carotid Plaque and Vascular Risk
-
Nov 20, 2026, 13:50Lara Kurdi: A Presentation of Triple-Positive Antiphospholipid Syndrome
-
Nov 20, 2026, 13:46Rahul Bohra: Beyond Platelet Counts – The Lived Experience of ITP
-
Nov 20, 2026, 13:34Yohei Hisada: How Well Do Mouse Leukemia Models Reflect Human Disease?
-
Nov 20, 2026, 13:20Ilenia Calcaterra: The Inferior Thyroid Arteries as a Window Into Cardiovascular Risk
-
Nov 20, 2026, 13:03Does Being Fit Protect Against VTE? – RPTH Journal
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance